Please login to the form below

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market. But recruitment is also one of the biggest challenges for trials. More than four in five studies fail to meet their recruitment deadlines, which can result in costly delays for sponsors and puts sites under increasing pressure. 

This issue has been exacerbated by the COVID-19 pandemic; with many trials initially put on hold and now restarting, sponsors want to make up for lost time by accelerating patient recruitment and retention. However, clinical trial staff are struggling to clear this enrollment backlog.

This webinar will explore some of the key challenges to patient recruitment particularly since COVID-19, and highlight how a 'boots on the ground' approach via Clinical Enrollment Managers (CEMs) can help supercharge patient recruitment and retention strategy by:

  • Understanding the local environment and culture in each country where sites are based
  • Working with sites and developing strategies to help them overcome recruitment barriers
  • Sustained community engagement within key patient populations, including those who are traditionally underrepresented in trials


13th June 2022

Share

Tags

Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom

Latest content on this profile

Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient
Innovative Trials
FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
Innovative Trials and Pfizer invite you to attend the live webinar
Innovative Trials
Innovative Trials opens first US office
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press release here: https://bit.ly/39QVvpD Innovative Trials website: https://bit.ly/3OS4ru1 Follow our social media. LinkedIn: https://bit.ly/3zfIhLs Instagram: https://bit.ly/3zeP7AY Twitter: https://bit.ly/3zLqL3z Facebook: https://bit.ly/3PIjXZS
Innovative Trials
Accelerating patient recruitment post-COVID-19
COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.
Innovative Trials
Innovative Trials opens first US office
The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina
Innovative Trials
Windrush Day
Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation
Innovative Trials